Growth Metrics

Rigel Pharmaceuticals (RIGL) Current Leases (2016 - 2025)

Historic Current Leases for Rigel Pharmaceuticals (RIGL) over the last 14 years, with Q3 2025 value amounting to $594000.0.

  • Rigel Pharmaceuticals' Current Leases rose 2746.78% to $594000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $594000.0, marking a year-over-year increase of 2746.78%. This contributed to the annual value of $285000.0 for FY2024, which is 5881.5% down from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Current Leases stood at $594000.0 for Q3 2025, which was up 2746.78% from $517000.0 recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Current Leases high stood at $9.9 million for Q4 2021, and its period low was $285000.0 during Q4 2024.
  • For the 5-year period, Rigel Pharmaceuticals' Current Leases averaged around $3.3 million, with its median value being $692000.0 (2023).
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Current Leases plummeted by 9458.78% in 2023, and later surged by 5790.65% in 2024.
  • Quarter analysis of 5 years shows Rigel Pharmaceuticals' Current Leases stood at $9.9 million in 2021, then crashed by 88.55% to $1.1 million in 2022, then crashed by 38.92% to $692000.0 in 2023, then crashed by 58.82% to $285000.0 in 2024, then skyrocketed by 108.42% to $594000.0 in 2025.
  • Its Current Leases was $594000.0 in Q3 2025, compared to $517000.0 in Q2 2025 and $456000.0 in Q1 2025.